CollabRx to Present at Biotech Showcase™ 2013

  CollabRx to Present at Biotech Showcase™ 2013

Biotech Showcase 2013

Business Wire

SAN FRANCISCO -- January 4, 2013

CollabRx, Inc. (NASDAQ: CLRX), a data analytics company focused on genomics,
today announced that Chairman and CEO Thomas R. Mika is scheduled to present
at Biotech Showcase™ 2013 on Wednesday, January 9, 2013, at 2:45 p.m. Pacific
Standard Time. The January 9-11 conference is to be held at the Parc55 Wyndham
San Francisco-Union Square in San Francisco.

Now in its fifth year, Biotech Showcase™ is an investor and partnering
conference that brings together healthcare companies, investors and
pharmaceutical executives. Nearly 1,400 were in attendance at last year’s
event.

CollabRx uses cloud-based expert systems to inform healthcare decision-making
by aggregating and contextualizing the world’s knowledge on molecular medicine
with specific insights from the nation’s top clinical experts. The company
combines proprietary content and technology to provide clinically relevant and
dynamically updated knowledge on clinical trials, drugs, biologics and other
information relevant for cancer treatment planning. This knowledge is
supported by CollabRx’s large and growing network of over 50 leading clinical
practitioners in the United States. While CollabRx and its advisors do not
provide specific treatment recommendations, this clinically relevant knowledge
is a key part of the “context engine” for informing healthcare
decision-making.

About Biotech Showcase™ 2013

Biotech Showcase™ is an investor and partnering conference devoted to
providing private and public biotechnology and life sciences companies with an
opportunity to present to, and meet with, investors and pharmaceutical
executives in one place during the course of one of the industry's largest
annual healthcare investor conferences. Investors and biopharmaceutical
executives from around the world gather in San Francisco during this critical
week, which is widely viewed as setting the tone for the coming year. For more
information, please visit www.ebdgroup.com/bts.

About CollabRx

CollabRx, Inc. (NASDAQ: CLRX) is a data analytics company and a leader in
cloud-based expert systems to inform health care decision-making. CollabRx
uses information technology to aggregate and contextualize the world’s
knowledge on genomics-based medicine with specific insights from the nation’s
top cancer experts starting with the area of greatest need: advanced cancers
in patients who have effectively exhausted the standard of care. More
information may be obtained at http://www.collabrx.com.

Contact:

CollabRx, Inc.
Thomas R. Mika, Chairman and CEO, 415-248-5350
or
Robert Ferri Partners, LLC
Robert Ferri, 415-575-1589 (direct)
robert.ferri@robertferri.com
 
Press spacebar to pause and continue. Press esc to stop.